Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

NCT04721301 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic
Pancreatic Cancer Metastatic

Interventions

COMBINATION_PRODUCT: Nivolumab plus Ipilimumab plus Maraviroc

Sponsor

University Hospital Heidelberg

Collaborators

[object Object]